AX-1602

N/A

Report date: 2022/03/14 17:17:09

Base Information

Drug NameAX-1602
Drug Alias NameAX-1602
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonistsAlpha adrenergic receptor agonistsCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptorSerotonin 1a (5-HT1a) receptorAlpha adrenergic receptor
Therapy Area/IndicationsPsoriasisVitiligoDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAxim Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesAxim Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisVitiligoDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A